MK-1496

MK-1496 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-1496, covering 2012-10-26 to 2012-10-26. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Study of MK-1496 in Patients With Advanced Solid Tumor (MK-1496-002 AM 4)(COMPLETED) [Phase 1]